Environment, Inflammation and Metabolic Diseases Study
Qifu Li
8,000 participants
Dec 25, 2020
OBSERVATIONAL
Conditions
Summary
The aim is to establish an effective and practical early warning model for endocrine and metabolic diseases based on an environmental-gene-protein panoramic network, to uncover new mechanisms underlying the onset and progression of these diseases, and to screen for novel therapeutic targets.
Eligibility
Inclusion Criteria1
- All individuals who voluntarily participated in the physical examination
Exclusion Criteria1
- Participants with incomplete data
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
A single observational cohort of study participants undergoing baseline biochemical screening for autonomous aldosterone secretion (AAS). No experimental interventions or treatments are administered. All participants receive standard clinical care and undergo standardized baseline assessments, including measurement of plasma aldosterone concentration (PAC) and plasma renin concentration (PRC) for AAS classification, as well as collection of demographic, clinical, biochemical, anthropometric data and biospecimens for proteomic analysis.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07512609